// App-Quantinova.ai

1592 : JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Researchers

Presenter

  • Elisa Rumi

Principal Investigators

  • Daniela Pietra

  • Chiara Elena

  • Mario Cazzola

  • Ilaria Carola Casetti

  • Emanuela San-Antonio

  • Cesare Astori

  • Chiara Milanesi

  • Marta Bellini

  • Emanuela Boveri

  • Virginia Ferretti

  • Cristiana Pascutto

Medical Centers

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Hematology Oncology, IRCCS Policlinico S. Matteo Foundation and University of Pavia, Pavia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • N-Acylethanolamine acid amidase

  • White Blood Cell

Drug/Treatment

  • Erythropoietin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved